Search Results - "Lutz, Werner K"

Refine Results
  1. 1

    CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug by Vogl, Silvia, Lutz, Roman W, Schönfelder, Gilbert, Lutz, Werner K

    Published in PloS one (16-03-2015)
    “…Currently, genotyping of patients for polymorphic enzymes responsible for metabolic elimination is considered a possibility to adjust drug dose levels. For a…”
    Get full text
    Journal Article
  2. 2

    Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose–response relationships, exemplified for mutagenicity data by Lutz, Werner K., Lutz, Roman W.

    Published in Mutation research (01-08-2009)
    “…Strongly sublinear dose–response relationships (slope increasing with dose) raise the question about a putative threshold dose below which no biologically…”
    Get full text
    Journal Article
  3. 3

    Metabolic Profiling of Glucuronides in Human Urine by LC−MS/MS and Partial Least-Squares Discriminant Analysis for Classification and Prediction of Gender by Lutz, Ursula, Lutz, Roman W, Lutz, Werner K

    Published in Analytical chemistry (Washington) (01-07-2006)
    “…Mass spectrometry (MS) is increasingly being used for metabolic profiling, but detection modes such as constant neutral loss or multiple reaction monitoring…”
    Get full text
    Journal Article
  4. 4

    Nonmonotonic Dose-Response Relationships: Mechanistic Basis, Kinetic Modeling, and Implications for Risk Assessment by Conolly, Rory B., Lutz, Werner K.

    Published in Toxicological sciences (01-01-2004)
    “…Dose-response curves for the first interaction of a chemical with a biochemical target molecule are usually monotonic; i.e., they increase or decrease over the…”
    Get full text
    Journal Article
  5. 5

    Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity by Lutz, Ursula, Bittner, Nataly, Ufer, Mike, Lutz, Werner K.

    “…Drug–drug and food–drug interactions are often due to an inhibition or induction of drug-metabolizing cytochrome P450 (CYP) enzymes and may result in…”
    Get full text
    Journal Article
  6. 6

    Correction: CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug by Vogl, Silvia, Lutz, Roman W, Schönfelder, Gilbert, Lutz, Werner K

    Published in PloS one (13-04-2015)
    “…According to the study design, which also designated phenotyping for CYP2D6, 10 mg dextromethorphan in water (DEX, as dextromethorphan hydrobromide…”
    Get full text
    Journal Article
  7. 7

    Ochratoxin A: 13-Week Oral Toxicity and Cell Proliferation in Male F344/N Rats by Rached, Eva, Hard, Gordon C., Blumbach, Kai, Weber, Klaus, Draheim, Regina, Lutz, Werner K., Özden, Sibel, Steger, Ulrich, Dekant, Wolfgang, Mally, Angela

    Published in Toxicological sciences (01-06-2007)
    “…Ochratoxin A (OTA) is nephrotoxic and a potent renal carcinogen. Male rats are most susceptible to OTA toxicity, and chronic administration of OTA (70 and 210…”
    Get full text
    Journal Article
  8. 8

    Metabolite profiling in human urine by LC–MS/MS: Method optimization and application for glucuronides from dextromethorphan metabolism by Lutz, Ursula, Bittner, Nataly, Lutz, Roman W., Lutz, Werner K.

    “…Analysis of human urine for specific compounds or metabolites is an established method for biomonitoring occupational or environmental exposures. Modern liquid…”
    Get full text
    Journal Article
  9. 9

    Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease by Völkel, Wolfgang, Sicilia, Tina, Pähler, Axel, Gsell, W., Tatschner, Thomas, Jellinger, Kurt, Leblhuber, Friedrich, Riederer, Peter, Lutz, Werner K., Götz, Mario E.

    Published in Neurochemistry international (01-06-2006)
    “…In the last decade an important role for the progression of neuronal cell death in Alzheimer's disease (AD) has been ascribed to oxidative stress…”
    Get full text
    Journal Article
  10. 10

    Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma by Kroiss, Matthias, Quinkler, Marcus, Lutz, Werner K., Allolio, Bruno, Fassnacht, Martin

    Published in Clinical endocrinology (Oxford) (01-11-2011)
    “…Summary Mitotane [1‐(2‐chlorophenyl)‐1‐(4‐chlorophenyl)‐2,2‐dichloroethane, (o,p’‐DDD)] is the only drug approved for the treatment for adrenocortical…”
    Get full text
    Journal Article
  11. 11

    Strategies in case of positive in vivo results in genotoxicity testing by Thybaud, Véronique, MacGregor, James T., Müller, Lutz, Crebelli, Riccardo, Dearfield, Kerry, Douglas, George, Farmer, Peter B., Gocke, Elmar, Hayashi, Makoto, Lovell, David P., Lutz, Werner K., Marzin, Daniel, Moore, Martha, Nohmi, Takehiko, Phillips, David H., Van Benthem, Jan

    Published in Mutation research (16-08-2011)
    “…At the 2009 International Workshop on Genotoxicity Testing in Basel, an expert group gathered to provide guidance on suitable follow-up tests to describe risk…”
    Get full text
    Journal Article
  12. 12

    LC–MS/MS analysis of dextromethorphan metabolism in human saliva and urine to determine CYP2D6 phenotype and individual variability in N-demethylation and glucuronidation by Lutz, Ursula, Völkel, Wolfgang, Lutz, Roman W., Lutz, Werner K.

    “…In order to establish a fast screening method for the determination of the CYP2D6 metabolic phenotype a sensitive LC–MS/MS assay to quantify dextromethorphan…”
    Get full text
    Journal Article
  13. 13

    Comparative Assessment of the Inhibition of Recombinant Human CYP19 (Aromatase) by Azoles Used in Agriculture and as Drugs for Humans by Trösken, Eva R., Scholz, Karoline, Lutz, Roman W., Völkel, Wolfgang, Zarn, Jürg A., Lutz, Werner K.

    Published in Endocrine research (01-01-2004)
    “…Azoles (imidazoles and triazoles) are used as antifungal agents in agriculture and in medicine, and also for antiestrogen therapy, e.g., for breast cancer…”
    Get full text
    Journal Article
  14. 14

    Different Types of Combination Effects for the Induction of Micronuclei in Mouse Lymphoma Cells by Binary Mixtures of the Genotoxic Agents MMS, MNU, and Genistein by Lutz, Werner K., Tiedge, Oliver, Lutz, Roman W., Stopper, Helga

    Published in Toxicological sciences (01-08-2005)
    “…Distinction between dose addition and response addition for the analysis of the toxicity of mixtures may allow differentiation of the components regarding…”
    Get full text
    Journal Article
  15. 15

    The Viracept (nelfinavir)—Ethyl methanesulfonate case: A threshold risk assessment for human exposure to a genotoxic drug contamination? by Lutz, Werner K.

    Published in Toxicology letters (12-11-2009)
    “…In May 2007, the F. Hoffmann-La Roche Company became aware of a contamination of Viracept (nelfinavir) tablets by the mutagenic DNA-ethylating agent ethyl…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Biomarkers of Furan Exposure by Metabolic Profiling of Rat Urine with Liquid Chromatography-Tandem Mass Spectrometry and Principal Component Analysis by Kellert, Marco, Wagner, Silvia, Lutz, Ursula, Lutz, Werner K

    Published in Chemical research in toxicology (01-03-2008)
    “…Furan has been found in a number of heated food items and is carcinogenic in the liver of rats and mice. Estimates of human exposure on the basis of…”
    Get full text
    Journal Article
  18. 18

    Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk +/− mouse lymphoma cells by Kellert, Marco, Brink, Andreas, Richter, Ingrid, Schlatter, Josef, Lutz, Werner K.

    Published in Mutation research (08-12-2008)
    “…Furan is found in various food items and is cytotoxic and carcinogenic in the liver of rats and mice. Metabolism of furan includes the formation of an…”
    Get full text
    Journal Article
  19. 19

    Comparison of lanosterol-14α-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles by Trösken, Eva R., Adamska, Magdalena, Arand, Michael, Zarn, Jürg A., Patten, Christopher, Völkel, Wolfgang, Lutz, Werner K.

    Published in Toxicology (Amsterdam) (10-11-2006)
    “…Inhibition of fungal lanosterol-14α-demethylase (CYP51) is the working principle of the antifungal activity of azoles used in agriculture and medicine…”
    Get full text
    Journal Article
  20. 20

    Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC–MS/MS method for the analysis of estradiol product formation by Trösken, Eva R., Fischer, Kathrin, Völkel, Wolfgang, Lutz, Werner K.

    Published in Toxicology (Amsterdam) (15-02-2006)
    “…Azoles are used as fungicides in agriculture or antifungal drugs in medicine. Their therapeutic activity is based on the inhibition of fungal…”
    Get full text
    Journal Article